Description

Our next Speaker Series will be a discussion on how to think about your clinical trial execution strategy post (and during) a pandemic. 

About this Event In this session, we will review 5 critical questions companies should be asking themselves as they prepare to execute on their clinical trials. As Sponsors begin to shift from a reactive to a more proactive way of approaching the impact that the coronavirus has indelibly had on clinical trial conduct, the answers to these 5 questions are critical to future success. 

From prioritizing patient centricity in study design to implementing technology solutions to choosing the right partner, this session will provide a structured framework on how to get started on your company’s transformation (be it digital or process). 

We hope you can join us! Thank you in advance for your attendance and willingness to share the best way forward for our trials, patients and our community. Upon registration you will receive the Zoom dial-in at the bottom of your confirmation email. Please feel free to distribute this event and any questions,

 contact crumrill@hallorancg.com